HDL Therapeutics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
601 21st St Ste 300, Vero Beach, Florida...Phone Number
(772) 453-2770Website
www.hdltherapeutics.comRevenue
<$5 MillionIndustry
About HDL Therapeutics
HDL Therapeutics, Inc. is pioneering innovative treatments for atherosclerosis, focusing on improving disease management and treatment for patients. Their flagship product, the PDS-2 System, is the only FDA-approved therapy that utilizes HDL (good cholesterol) to reduce coronary artery plaques in patients with Homozygous Familial Hypercholesterolemia (HoFH). The company is led by a team of experts with extensive experience in the pharmaceutical, biotechnology, and medical device sectors. HDL Therapeutics aims to transform the landscape of atherosclerosis treatment through their novel approach.Explore more
SIC Code 28,283NAICS Code 32,325Show moreHDL Therapeutics Org Chart
Compare Similar Companies to HDL Therapeutics
Compare insights from companies similar to HDL Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
HDL Therapeutics Tech Stack
A closer look at the technologies used by HDL Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HDL Therapeutics
Sign Up For FreeTo access detailed company insights
HDL Therapeutics, Inc. is pioneering innovative treatments for atherosclerosis, focusing on improving disease management and treatment for patients. Their flagship product, the PDS-2 System, is the only FDA-approved therapy that utilizes HDL (good cholesterol) to reduce coronary artery plaques in patients with Homozygous Familial Hypercholesterolem... Read More